SMTL ID : 8so3.1

CryoEM structure of a therapeutic antibody (favezelimab) bound to human LAG3

Coordinates

PDB Format

Method

ELECTRON MICROSCOPY

Oligo State

hetero-2-2-2-mer

Ligands

4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)

NAG.1: 5 residues within 4Å: Chain A: N.188, S.190, F.225 Chain D: H.220, A.222 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:F.225 Hydrogen bonds: A:N.188, A:S.190, A:S.190 NAG.2: 1 residues within 4Å: Chain A: N.250 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.250 NAG.3: 3 residues within 4Å: Chain A: M.254, Y.255, N.256 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.256 NAG.4: 4 residues within 4Å: Chain A: E.223 Chain D: N.188, S.190, F.225 1 PLIP interactions: 1 interactions with chain D Hydrogen bonds: D:N.188

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mishra, A.K. et al., CryoEM structure of a therapeutic antibody (favezelimab) bound to human LAG3 determined using a bivalent Fab as fiducial marker. Structure (2023)

Release Date

2023-09-06

Peptides

Lymphocyte activation gene 3 protein: AD
favezelimab Fab heavy chain: BE
favezelimab Fab light chain: CF

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

D
X

B
H

E
Y

C
L

F
Z

Lymphocyte activation gene 3 protein

favezelimab Fab heavy chain

favezelimab Fab light chain

Related Entries With Identical Sequence